Privia Health Group (PRVA) Expected to Announce Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) is anticipated to post its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to post earnings of $0.0906 per share and revenue of $610.72 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Thursday, August 6th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.07 by $0.12. The firm had revenue of $632.63 million during the quarter, compared to analysts’ expectations of $597.33 million. Privia Health Group had a net margin of 1.19% and a return on equity of 3.52%. Privia Health Group’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.24 EPS. On average, analysts expect Privia Health Group to post $0.27 EPS for the current fiscal year and $0.41 EPS for the next fiscal year.

Privia Health Group Stock Performance

Shares of PRVA opened at $21.84 on Thursday. Privia Health Group has a fifty-two week low of $18.92 and a fifty-two week high of $28.82. The company has a market capitalization of $2.79 billion, a PE ratio of 104.00 and a beta of 0.80. The stock has a fifty day moving average of $20.86 and a two-hundred day moving average of $22.67.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Citigroup restated a “buy” rating on shares of Privia Health Group in a report on Thursday, July 23rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a report on Tuesday, September 29th. Finally, Canaccord Genuity Group set a $32.00 price objective on shares of Privia Health Group in a report on Friday, August 7th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Privia Health Group Company Profile

Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.

Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.